Fig. 7From: Celastrol attenuates streptozotocin-induced diabetic cardiomyopathy in mice by inhibiting the ACE / Ang II / AGTR1 signaling pathwayIdentifcation of the common potential targets celastrol against DCM. (A) The 2D molecular structure of celastrol. (B) The distribution map of 100 candidate targets of celastrol collected from the SwissTargetPrediction database. (C) Venn diagram of the intersection of DCM from CTD and GeneCards database. (D) PPI network of core genesBack to article page